Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 5Phase 1/2 2Phase EARLY_PHASE1 1Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Melanoma 2Skin Neoplasms 1Pancreatic Neoplasms 1Colorectal Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Oncolytic Virotherapy 2tucatinib 1trifluridine tipiracil drug combination 1tribenoside (combination) 1tribenoside 1trastuzumab deruxtecan 1tipiracil 1sotorasib 1sintilimab 1regorafenib 1polyethylene glycol 400 1penpulimab 1palbociclib 1montelukast 1encorafenib 1binimetinib 1balstilimab 1adagrasib 1Trifluridine 1Tobacco Use Cessation Devices 1Tablets 1Suppositories 1Standard of Care 1Specimen Handling 1Receptor Protein-Tyrosine Kinases 1Radiosurgery 1Polyethylene Glycols 1Pentoxifylline 1Panitumumab 1Oxaliplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Colorectal Neoplasms × binimetinib × Clear all
NCT04870034 2023-12-22

Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer

Roswell Park Cancer Institute

Phase EARLY_PHASE1 Withdrawn
GastrointestinalThoracic

Adenocarcinoma of Lung, Pancreatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡